The Valley Desk

NCT06744647 · Interventional trial

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Overall registry status Active not recruiting

Phase 2

Conditions AMR, Antibody-Mediated Rejection, Biopsy-proven Histologic Scores, Kidney Transplantation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov